AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE

N/A

Manufactured by The Kroger Co.

376 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE

AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by The Kroger Co.. The most commonly reported adverse reactions for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE include RASH, ERYTHEMA, ACNE, DRY SKIN, SUNBURN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE.

Top Adverse Reactions

RASH13 reports
ERYTHEMA11 reports
ACNE10 reports
DRY SKIN10 reports
SUNBURN9 reports
MALIGNANT MELANOMA8 reports
OFF LABEL USE8 reports
CONDITION AGGRAVATED7 reports
HEADACHE7 reports
APPLICATION SITE ERYTHEMA6 reports
DERMATITIS6 reports
DIARRHOEA6 reports
DRUG INEFFECTIVE6 reports
FATIGUE6 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION6 reports
PAIN6 reports
SKIN EXFOLIATION6 reports
SWELLING FACE6 reports
ARTHRALGIA5 reports
BLISTER5 reports
DEPRESSION5 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION5 reports
PHOTOSENSITIVITY REACTION5 reports
PRODUCT USE ISSUE5 reports
PRURITUS5 reports
PSORIASIS5 reports
SKIN BURNING SENSATION5 reports
XEROSIS5 reports
APPLICATION SITE PAIN4 reports
BASAL CELL CARCINOMA4 reports
DRUG HYPERSENSITIVITY4 reports
DRY EYE4 reports
HYPERSENSITIVITY4 reports
PAIN OF SKIN4 reports
PIGMENTATION DISORDER4 reports
RASH ERYTHEMATOUS4 reports
SKIN HYPERPIGMENTATION4 reports
SOMNOLENCE4 reports
THERAPEUTIC RESPONSE UNEXPECTED4 reports
ANXIETY3 reports
ASTHENIA3 reports
BURNING SENSATION3 reports
CHEILITIS3 reports
COUGH3 reports
ECZEMA3 reports
HEART RATE INCREASED3 reports
HOSPITALISATION3 reports
ILLNESS3 reports
INTENTIONAL PRODUCT MISUSE3 reports
MALAISE3 reports
MOOD ALTERED3 reports
MUSCULOSKELETAL STIFFNESS3 reports
OVERDOSE3 reports
PAIN IN EXTREMITY3 reports
PRODUCT DOSE OMISSION ISSUE3 reports
SENSITIVE SKIN3 reports
SKIN DISCOLOURATION3 reports
SKIN IRRITATION3 reports
SYSTEMIC LUPUS ERYTHEMATOSUS3 reports
UNDERDOSE3 reports
URTICARIA3 reports
WEIGHT DECREASED3 reports
ABDOMINAL DISCOMFORT2 reports
ABDOMINAL PAIN UPPER2 reports
ABNORMAL LOSS OF WEIGHT2 reports
ACNE CYSTIC2 reports
ADVERSE EVENT2 reports
APPLICATION SITE DISCHARGE2 reports
APPLICATION SITE DISCOLOURATION2 reports
APPLICATION SITE EXFOLIATION2 reports
BACK PAIN2 reports
CHOLECYSTITIS ACUTE2 reports
CHOLESTASIS2 reports
CONTUSION2 reports
DEATH2 reports
DECREASED APPETITE2 reports
DRY MOUTH2 reports
DYSPHAGIA2 reports
DYSPNOEA2 reports
EYE IRRITATION2 reports
EYE PAIN2 reports
GASTROINTESTINAL HAEMORRHAGE2 reports
HYPERHIDROSIS2 reports
IMMUNE SYSTEM DISORDER2 reports
IMMUNE MEDIATED HEPATITIS2 reports
INFECTION2 reports
INFLAMMATION2 reports
INTENTIONAL PRODUCT USE ISSUE2 reports
INTENTIONAL UNDERDOSE2 reports
JOINT SWELLING2 reports
LENTIGO2 reports
LUNG NEOPLASM MALIGNANT2 reports
MELANOCYTIC NAEVUS2 reports
MILIARIA2 reports
MIOSIS2 reports
MUSCLE SPASMS2 reports
MYALGIA2 reports
NAUSEA2 reports
PERIPHERAL SWELLING2 reports
PNEUMONIA2 reports

Report Outcomes

Out of 143 classified reports for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE:

Serious 38.5%Non-Serious 61.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female81 (64.8%)
Male44 (35.2%)

Reports by Age

Age 666 reports
Age 625 reports
Age 474 reports
Age 544 reports
Age 584 reports
Age 654 reports
Age 694 reports
Age 403 reports
Age 433 reports
Age 443 reports
Age 503 reports
Age 563 reports
Age 683 reports
Age 723 reports
Age 763 reports
Age 172 reports
Age 192 reports
Age 282 reports
Age 342 reports
Age 412 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE?

This profile reflects 376 FDA FAERS reports that mention AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE?

Frequently reported terms in FAERS include RASH, ERYTHEMA, ACNE, DRY SKIN, SUNBURN, MALIGNANT MELANOMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE?

Labeling and FAERS entries often list The Kroger Co. in connection with AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.